{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FXR"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FXR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXR\",,,,,undefined,":{"symbol":"FXR","market":"US","secType":"STK","nameCN":"First Trust Industrials/Producer Durables AlphaDEX Fund","latestPrice":76.81,"timestamp":1752264000000,"preClose":77.63,"halted":0,"volume":61099,"hourTrading":{"tag":"盘后","latestPrice":76.81,"preClose":76.81,"latestTime":"16:10 EDT","volume":5,"amount":382.54,"timestamp":1752264603443},"delay":0,"floatShares":24250002,"shares":24250002,"eps":0,"marketStatus":"Market Closed","change":-0.82,"latestTime":"07-11 16:00:00 EDT","open":77.14,"high":77.1462,"low":76.79,"amount":4704756.83975,"amplitude":0.004588,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":77.63,"sharesOutstanding":24250002,"nav":77.65,"aum":1883012655.3,"dividendRate":0.007551,"bidAskSpread":0.000948,"postHourTrading":{"tag":"盘后","latestPrice":76.81,"preClose":76.81,"latestTime":"16:10 EDT","volume":5,"amount":382.54,"timestamp":1752264603443},"volumeRatio":1.728939689054627,"impliedVol":0.1051,"impliedVolPercentile":0.732},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXR\",,,,,undefined,":{"symbol":"FXR","floatShares":24250002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.728939689054627,"shares":24250002,"dividePrice":0.58,"high":77.1462,"amplitude":0.004588,"preClose":77.63,"low":76.79,"week52Low":60.015,"pbRate":"--","week52High":83.71,"institutionHeld":0,"latestPrice":76.81,"eps":0,"divideRate":0.007551,"volume":61099,"delay":0,"ttmEps":0,"open":77.14,"prevYearClose":74.81,"prevWeekClose":76.79,"prevMonthClose":74.22,"prevQuarterClose":74.22,"fiveDayClose":76.79,"twentyDayClose":73.07,"sixtyDayClose":66.07},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FXR\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FXR\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522004954","title":"Organovo Completes Sale of FXR Program to Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2522004954","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522004954?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:52","pubTimestamp":1742917928,"startTime":"0","endTime":"0","summary":"Organovo  said Tuesday that it has completed the sale of its farnesoid X receptor, or FXR, program to Eli Lilly .The agreement was announced in February, with Organovo saying it will sell the FXR program for an upfront payment of $10 million and potential milestone payments of up to $50 million.Eli Lilly has now acquired all commercial and intellectual property rights to the FXR program and will be responsible for its future clinical development.Price: 2.92, Change: -0.07, Percent Change: -2.34","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0820561818.USD","LU0256863902.USD","IE0002141913.USD","LU0823416689.USD","LU2264538146.SGD","LU0354030511.USD","LU0640476718.USD","LU1989771016.USD","LU1069344957.HKD","SGXZ51526630.SGD","LU0096364046.USD","IE00B4R5TH58.HKD","LU0106261372.USD","BK4139","LU0006306889.USD","LU1988902786.USD","SG9999014906.USD","LU1974910355.USD","LU2112291526.USD","LU0708995401.HKD","IE00B1BXHZ80.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","SG9999015952.SGD","SG9999013999.USD","LU2237443895.HKD","LU1093756168.USD","BK4534","LU0058720904.USD","LU0289739699.SGD","ONVO","LU1868837300.USD","FXR","BK4585","LU0471298694.HKD","SG9999018865.SGD","LLY","LU1868836591.USD","SGXZ81514606.USD","LU2063271972.USD","LU1366192091.USD","LU1093756325.SGD","LU0238689110.USD","LU1548497426.USD","LU0417517546.SGD","LU2089984988.USD","LU2237438978.USD","SG9999015986.USD","LU2361045086.USD","LU2023250504.SGD"],"gpt_icon":0},{"id":"2522800949","title":"Press Release: Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2522800949","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522800949?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:25","pubTimestamp":1742916300,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 25, 2025  -- Organovo Holdings, Inc.  , a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease , today announced the successful close of the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company  .   The transaction was completed on March 25, 2025.With the closing, Organovo receives an upfront payment, with future milestones to be paid as FXR314 hits key regulatory and commercial milestones. Lilly is acquiring all commercial and intellectual property rights to Organovo's FXR program for worldwide development and will be responsible for all future clinical development.Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional  human tissues as candidates for drug development. The company has proprietary technology used to build 3D human tissues that mimic key aspects of native human tissue composition, archit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU0114720955.EUR","LU0203201768.USD","LU0096364046.USD","SG9999014880.SGD","LU0385154629.USD","LU0289739699.SGD","IE0009355771.USD","LU0708995401.HKD","LU2360106947.USD","LU2106854487.HKD","LU2461242641.AUD","LU0354030511.USD","LU1917777945.USD","LU1064131342.USD","LU0466842654.USD","LU2237443465.HKD","LU2602419157.SGD","LU0256863902.USD","IBD","SG9999014906.USD","IE00BK4W5M84.HKD","SG9999015986.USD","ONVO","LU0417517546.SGD","LU0471298694.HKD","LU1988902786.USD","IE0004445239.USD","BK4534","BK4139","FXR","LU1291159041.SGD","LU1623119135.USD","LU1868836757.USD","LU1035775433.USD","IE00BJJMRZ35.SGD","LU0109391861.USD","LU1868837300.USD","LU1983299246.USD","LU2063271972.USD","SG9999014898.SGD","SGXZ51526630.SGD","LU1548497426.USD","LU1720051108.HKD","LU0456855351.SGD","LLY","LU0471298777.SGD","SG9999017495.SGD","LU1057294990.SGD","LU2237443622.USD"],"gpt_icon":0},{"id":"2514120290","title":"Why Eli Lilly Stock Popped Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2514120290","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514120290?lang=en_us&edition=fundamental","pubTime":"2025-02-26 00:35","pubTimestamp":1740501300,"startTime":"0","endTime":"0","summary":"Eli Lilly is buying a new drug and lowering prices on an existing one.GLP-1 weight loss drug Zepbound is getting cheaper.This will make Lilly's product relatively more attractive, and help to win market share.Lacking data on precisely what Lilly intends to pay for Organovo's new drug, I'll focus on the GLP-1 news today. And I'll just point out that it seems calculated to make Lilly's product relatively more attractive than competing diet drugs from both Novo Nordisk and Hims & Hers Health.Lower prices, raise market share. It's as simple as that -- and good enough for a 2.6% stock price bump.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/25/why-eli-lilly-stock-popped-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0943347566.SGD","LU1093756325.SGD","LU0198837287.USD","LU1069344957.HKD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU1868836757.USD","LU1548497426.USD","LU0106261372.USD","LU1974910355.USD","BK4007","LU0417517546.SGD","LU1551013425.SGD","BK4585","LU0320765059.SGD","GB00BDT5M118.USD","LU1093756168.USD","LU2491050071.SGD","SG9999014898.SGD","IE00BFTCPJ56.SGD","LU1989771016.USD","SGXZ81514606.USD","LU0354030438.USD","LU2361044865.SGD","LU2237438978.USD","LU1035775433.USD","IE00BJJMRZ35.SGD","LU2023250504.SGD","LU2063271972.USD","SGXZ99366536.SGD","SG9999001176.USD","LU0882574055.USD","LU0385154629.USD","LU2264538146.SGD","FXR","LU1720051017.SGD","SGXZ51526630.SGD","LU0289739699.SGD","LU1983299246.USD","LU0882574139.USD","LU0456855351.SGD","LU2237443895.HKD","LU2360106947.USD","LU2361045086.USD","LU2357305700.SGD","SG9999015952.SGD","IE00BK4W5M84.HKD","LU1280957306.USD","LU2089984988.USD","LLY"],"gpt_icon":1},{"id":"2514539091","title":"Organovo’s FXR program to be acquired by Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2514539091","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514539091?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:16","pubTimestamp":1740489406,"startTime":"0","endTime":"0","summary":"Organovo (ONVO) Holdings announced that Eli Lilly (LLY) and Company will acquire Organovo’s FXR program, including its lead asset, FXR314. Under th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organovos-fxr-program-to-be-acquired-by-eli-lilly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"3ae64dabd38a125634a5edcda736adba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organovos-fxr-program-to-be-acquired-by-eli-lilly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BK4W5M84.HKD","LU1868836914.USD","LU2237443382.USD","LU0417517546.SGD","LU1720051108.HKD","SGXZ81514606.USD","LU1267930730.SGD","LU1280957306.USD","LU1974910355.USD","FXR","SG9999015978.USD","LU0106261372.USD","LU0256863811.USD","IE0004445239.USD","LU2237438978.USD","LU0708995401.HKD","IE00BJLML261.HKD","LU2211815571.USD","LU0354030511.USD","LU2468319806.SGD","LU1366192091.USD","LU2237443978.SGD","LU0006306889.USD","SG9999015986.USD","GB00BDT5M118.USD","LU0097036916.USD","LU0238689110.USD","LU0289739699.SGD","LU1989771016.USD","LU1804176565.USD","BK4534","LU0820561818.USD","BK4599","IE00BJJMRZ35.SGD","LU2324357040.USD","BK4007","SG9999014880.SGD","SG9999014914.USD","LU2237443549.SGD","LU2360106947.USD","ONVO","LU0943347566.SGD","LU2491050071.SGD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2361044949.HKD","LU2023250504.SGD","LLY","LU0203201768.USD","SGXZ31699556.SGD"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FXR\",params:#limit:5,,,undefined,":[{"date":"2025-06-26","symbol":"FXR","amount":0.1217,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Industrials/Producer Durables AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"},{"date":"2025-03-27","symbol":"FXR","amount":0.1107,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"First Trust Industrials/Producer Durables AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-03-31"},{"date":"2024-12-13","symbol":"FXR","amount":0.1732,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust Industrials/Producer Durables AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"date":"2024-09-26","symbol":"FXR","amount":0.125,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-26","defaultRemindTime":1727357400000,"name":"First Trust Industrials/Producer Durables AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-30","payableDate":"2024-09-26","currency":"USD","dateTimestamp":1727323200000,"payDate":"2024-09-30"},{"date":"2024-06-27","symbol":"FXR","amount":0.1666,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"First Trust Industrials/Producer Durables AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-06-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FXR\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-23","recordDate":"2015-09-25","paymentDate":"2015-09-30","value":0.0568,"currency":"USD"},{"executeDate":"2015-12-23","recordDate":"2015-12-28","paymentDate":"2015-12-31","value":0.1063,"currency":"USD"},{"executeDate":"2016-03-23","recordDate":"2016-03-28","paymentDate":"2016-03-31","value":0.0308,"currency":"USD"},{"executeDate":"2016-06-22","recordDate":"2016-06-24","paymentDate":"2016-06-30","value":0.0591,"currency":"USD"},{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.0394,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FXR\",market:\"US\",delay:false,,,undefined,":{}}}